Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - mitozantrone hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - mitozantrone hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - aciclovir -

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - aciclovir -

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - calcium folinate, quantity: 10.8 mg/ml (equivalent: folinic acid, qty 10 mg/ml) - injection, solution - excipient ingredients: hydrochloric acid; sodium hydroxide; sodium chloride; water for injections - leucovorin calcium injection usp is indicated following high dose methotrexate therapy to reduce toxicity (leucovorin rescue). it is also indicated after inadvertent overdosage with methotrexate and in impaired methotrexate elimination.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - calcium folinate, quantity: 10.8 mg/ml (equivalent: folinic acid, qty 10 mg/ml) - injection, solution - excipient ingredients: water for injections; sodium hydroxide; sodium chloride; hydrochloric acid - leucovorin calcium injection usp is indicated following high dose methotrexate therapy to reduce toxicity (leucovorin rescue). it is also indicated after inadvertent overdosage with methotrexate and in impaired methotrexate elimination.

United States - English - NLM (National Library of Medicine)

pfizer canada inc. - mineral oil 14%, petrolatum 74.9%, phenylephrine hcl 0.25% -

Canada - English - Health Canada

pfizer canada inc., consumer healthcare division - tetrahydrozoline hydrochloride; zinc sulfate - liquid - .05%; .25% - tetrahydrozoline hydrochloride .05%; zinc sulfate .25% - vasoconstrictors

Canada - English - Health Canada

pfizer canada inc., consumer healthcare division - menthol; camphor; zinc oxide; chloral hydrate; hyoscyamine - ointment - .58%; .62%; 12.5%; .496%; .0001% - menthol .58%; camphor .62%; zinc oxide 12.5%; chloral hydrate .496%; hyoscyamine .0001% - antipruritics and local anesthetics

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - paracetamol, quantity: 1 g - injection, solution - excipient ingredients: glucose monohydrate; sodium citrate dihydrate; water for injections; glacial acetic acid; hydrochloric acid; sodium acetate trihydrate; sodium hydroxide - for the relief of mild to moderate pain and the reduction of fever where an intravenous route of administration is considered clinically necessary.